Current biomedical engineering strategies for gingival keratinized tissue augmentation: a narrative review
Biomedical Engineering Communications · 2026 · 5 (6) · 34
DOI: 10.53388/bmec2026034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Engineering Communications, 2026. Verfasst von Jiang-Tian Li und 6 weiteren Autor:innen.
Abstract (Originalsprache)
In clinical practice, patients with gingival recession or who require implant restoration due to tooth loss often face challenges with insufficient keratinized tissue width and thickness. Adequate keratinized tissue width and thickness are crucial for maintaining gingival health and implant stability. Conventional methods for widening keratinized tissue, such as free gingival grafts and connective tissue grafts, have limitations, including the need for a secondary surgical site and postoperative adverse reactions. The core premise of biomedical engineering strategies is to avoid harvesting materials from the patient's own oral cavity and instead rely on external sources. In recent years, advances in biomedical engineering have enabled the application of tissue-engineered biomaterials, composite scaffolds loaded with living cells, and growth factors targeting specific signaling pathways to augment gingival keratinized tissue. These approaches are most commonly employed for treating gingival recession, with increases in keratinized tissue width and thickness recorded as secondary outcomes. These biomaterials can be categorized by source into skin-derived, tooth-derived, placental-derived, and natural collagen-based scaffolds. The primary living cells used include fibroblasts, keratinocytes, and mesenchymal stem cells, while growth factors encompass both single growth factors and concentrates. In clinical practice, while biomedical engineering alternatives compared to autografts avoid traditional surgical donor site complications, alternatives face challenges such as significant tissue shrinkage and inconsistent augmentation outcomes. The future development of highly efficient augmentation materials, or the combination of microneedle-based local drug delivery to modify augmentation pathways, may offer novel research directions for gingival keratinized tissue augmentation.
Zitieren
APA
Li, J., Huang, G., Zhu, H., Chen, P., Wang, R., Zeng, Y., & Li, Z. (2026). Current biomedical engineering strategies for gingival keratinized tissue augmentation: a narrative review. Biomedical Engineering Communications, 5(6), 34. https://doi.org/10.53388/bmec2026034
Vancouver
Li J, Huang G, Zhu H, Chen P, Wang R, Zeng Y, et al. Current biomedical engineering strategies for gingival keratinized tissue augmentation: a narrative review. Biomedical Engineering Communications. 2026;5(6):34. doi:10.53388/bmec2026034
BibTeX
@article{Li2026,
author = {Li, Jiang-Tian and Huang, Guang-Hui and Zhu, Hai-Tao and Chen, Pei-Chi and Wang, Rui-Min and Zeng, Yu-Yu and Li, Ze-Jian},
title = {Current biomedical engineering strategies for gingival keratinized tissue augmentation: a narrative review},
journal = {Biomedical Engineering Communications},
year = {2026},
volume = {5},
number = {6},
pages = {34},
doi = {10.53388/bmec2026034}
}
EUVIMED